USA FINANCIAL FORMULAS’s Royalty Pharma RPRX Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Buy	+4,439	New	+$231K	0.05%	111

Other funds holding RPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

TIP

Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

USA FINANCIAL FORMULAS's RPRX Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Royalty Pharma (RPRX) in Q2 2026: 4,439 shares worth $249K. The stake represents 0.05% of the portfolio and ranks #111 among its holdings.

218 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

USA FINANCIAL FORMULAS held 4,439 shares of Royalty Pharma worth $249K as of Q2 2026.
Royalty Pharma was a new USA FINANCIAL FORMULAS position in Q2 2026.
Royalty Pharma made up 0.05% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #111 holding.
218 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.